Esculetin inhibits liver cancer by targeting glucose-6-phosphate isomerase mediated glycolysis

This study demonstrated the inhibitory effects of esculetin against liver cancer both in vitro and in vivo, demonstrating inhibition of glycolysis in liver cancer cells. In addition, the key glycolysis enzyme GPI was identified as a direct target of esculetin.